John Heinbockel

Kelly Bania

Leah Jordan

Mark Carden

Michael Montani

Edward Kelly

Simeon Gutman

Joseph Feldman

Paul Lejuez

Robert Ohmes

Rupesh Parikh

Scott Mushkin

Charles Cerankosky

Erica Eiler

Jacob Aiken-Phillips

Karen Short

Kendall Toscano

Kenneth Goldman

William Kirk

- Albertsons Companies reported **Q2 2025 adjusted identical sales growth of 2.2%**, driven by **23%** year-over-year digital sales growth and **19%** year-over-year pharmacy growth.  **[0001646972_2181021_3]** **[0001646972_2181021_6]** 
- The company increased its share repurchase authorization from **$2 billion to $2.75 billion** and executed a **$750 million** accelerated share repurchase.  **[0001646972_2181021_6]** 
- For fiscal year 2025, Albertsons updated its outlook, increasing the identical sales range to **2.2% to 2.75%** and adjusted EPS to **$2.16 to $2.19**, while maintaining adjusted EBITDA guidance of **$3.8 billion to $3.9 billion**.  **[0001646972_2181021_7]** 
- Strategic investments in digital, AI (including a partnership with OpenAI), and productivity initiatives are key, with **$1.5 billion** in productivity savings expected from fiscal 2025 through fiscal year 2027.  **[0001646972_2181021_4]** **[0001646972_2181021_5]** **[0001646972_2181021_8]**

Albertsons Companies Reports Q2 2025 Results and Updates FY2025 Outlook

- For Q2 2025, ACI reported **Identical Sales growth of +2.2%** and **Digital Sales growth of +23%**.  **[0001646972_2180957:0]** 
- The company's **Adjusted EPS was $0.44** and **Adjusted EBITDA reached $848 million** in Q2 2025.  **[0001646972_2180957:0]** 
- ACI is focused on strategic initiatives including driving customer growth through digital engagement, building its media business, enhancing the customer value proposition, and modernizing capabilities.  **[0001646972_2180957:0]** 
- The company aims to unlock **$1.5 billion in savings** through transformational productivity efforts.  **[0001646972_2180957:0]**

ACI announces Q2 2025 results

Albertsons Companies (ACI)